Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-27

Clinical Trial Update: Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular Degeneration

View source ↗

Summary

This clinical trial update covers the evaluation of rheohemapheresis and lutein supplementation for non-exudative age-related macular degeneration, with the cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lutein supplement (lutein)
  • Rheohemapheresis

Snippet

Sponsor: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Conditions: Age-related Macular Degeneration | Status: UNKNOWN